Genetic disease targeting creating antisense opportunity — antisense oligonucleotides (ASOs) — short synthetic DNA or RNA sequences designed to bind complementary mRNA sequences and modulate gene expression through RNase H-mediated degradation or steric blocking — enabling therapeutic targeting of previously undruggable genes and providing disease modification for genetic...

The growing burden of infectious diseases, increasing hospital-acquired infections, and rising awareness regarding advanced treatment options are contributing significantly to the expansion of the systemic antibiotics market. Healthcare systems across developed and emerging economies are focusing on improving infection management and strengthening antimicrobial therapies. The Systemic...